Acasti Pharma Valuation

ACST Stock  USD 3.40  0.01  0.29%   
At this time, the firm appears to be overvalued. Acasti Pharma shows a prevailing Real Value of $2.33 per share. The current price of the firm is $3.4. Our model approximates the value of Acasti Pharma from analyzing the firm fundamentals such as current valuation of 6.87 M, and Return On Equity of -0.48 as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor acquiring undervalued instruments and selling overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Price Book
0.4941
Enterprise Value
6.9 M
Enterprise Value Ebitda
(0.56)
Price Sales
208.3872
Enterprise Value Revenue
5.5008
Overvalued
Today
3.40
Please note that Acasti Pharma's price fluctuation is very risky at this time. Calculation of the real value of Acasti Pharma is based on 3 months time horizon. Increasing Acasti Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Acasti Pharma is useful when determining the fair value of the Acasti stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Acasti Pharma. Since Acasti Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Acasti Stock. However, Acasti Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  3.4 Real  2.33 Target  1.96 Hype  3.35 Naive  3.59
The real value of Acasti Stock, also known as its intrinsic value, is the underlying worth of Acasti Pharma Company, which is reflected in its stock price. It is based on Acasti Pharma's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Acasti Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Acasti Pharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
2.33
Real Value
6.74
Upside
Estimating the potential upside or downside of Acasti Pharma helps investors to forecast how Acasti stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Acasti Pharma more accurately as focusing exclusively on Acasti Pharma's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
-0.19-0.13-0.07
Details
Hype
Prediction
LowEstimatedHigh
0.173.357.76
Details
Naive
Forecast
LowNext ValueHigh
0.073.598.00
Details
2 Analysts
Consensus
LowTarget PriceHigh
1.781.962.18
Details

Acasti Pharma Investments

15.88 Million

Acasti Pharma Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Acasti Pharma's current stock value. Our valuation model uses many indicators to compare Acasti Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Acasti Pharma competition to find correlations between indicators driving Acasti Pharma's intrinsic value. More Info.
Acasti Pharma is rated fifth in beta category among related companies. It is rated fifth in net asset category among related companies making up about  53,138,348  of Net Asset per Beta. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Acasti Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Acasti Pharma's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Acasti Pharma's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Acasti Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Acasti Pharma and how it compares across the competition.

About Acasti Pharma Valuation

The stock valuation mechanism determines the current worth of Acasti Pharma on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Acasti Pharma. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Acasti Pharma based exclusively on its fundamental and basic technical indicators. By analyzing Acasti Pharma's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Acasti Pharma's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Acasti Pharma. We calculate exposure to Acasti Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Acasti Pharma's related companies.
Last ReportedProjected for 2024
Gross Profit-46.9 M-44.6 M
Pretax Profit Margin(115.46)(121.23)
Operating Profit Margin(62.87)(66.02)
Net Loss(115.46)(121.23)
Gross Profit Margin 0.70  0.74 

8 Steps to conduct Acasti Pharma's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Acasti Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Acasti Pharma's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Acasti Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Acasti Pharma's revenue streams: Identify Acasti Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Acasti Pharma's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Acasti Pharma's growth potential: Evaluate Acasti Pharma's management, business model, and growth potential.
  • Determine Acasti Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Acasti Pharma's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Acasti Pharma Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Acasti Pharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding7.5 M

Acasti Pharma Current Valuation Indicators

Valuation refers to the process of determining the present value of Acasti Pharma and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Acasti we look at many different elements of the entity such as Acasti's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Acasti Pharma's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Acasti Pharma's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Acasti Pharma, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Acasti Pharma's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Acasti Pharma's worth.
When determining whether Acasti Pharma is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Acasti Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Acasti Pharma Stock. Highlighted below are key reports to facilitate an investment decision about Acasti Pharma Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acasti Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
For more information on how to buy Acasti Stock please use our How to Invest in Acasti Pharma guide.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for Acasti Stock analysis

When running Acasti Pharma's price analysis, check to measure Acasti Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acasti Pharma is operating at the current time. Most of Acasti Pharma's value examination focuses on studying past and present price action to predict the probability of Acasti Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acasti Pharma's price. Additionally, you may evaluate how the addition of Acasti Pharma to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Is Acasti Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acasti Pharma. If investors know Acasti will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acasti Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.68)
Revenue Per Share
0.005
Return On Assets
(0.08)
Return On Equity
(0.48)
The market value of Acasti Pharma is measured differently than its book value, which is the value of Acasti that is recorded on the company's balance sheet. Investors also form their own opinion of Acasti Pharma's value that differs from its market value or its book value, called intrinsic value, which is Acasti Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acasti Pharma's market value can be influenced by many factors that don't directly affect Acasti Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acasti Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Acasti Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acasti Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.